Garcia Hamilton & Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,974
Closed -$579K 45
2017
Q3
$579K Sell
3,974
-4,797
-55% -$653K 1.5% 14
2017
Q2
$1.14M Sell
8,771
-7,673
-47% -$940K 1.57% 15
2017
Q1
$2.04M Sell
16,444
-13,271
-45% -$1.59M 1.81% 14
2016
Q4
$3.44M Sell
29,715
-1,676
-5% -$187K 1.99% 15
2016
Q3
$3.28M Sell
31,391
-494
-2% -$53.5K 1.93% 19
2016
Q2
$3.15M Sell
31,885
-1,412
-4% -$146K 1.9% 19
2016
Q1
$3.33M Buy
33,297
+4,127
+14% +$425K 1.94% 19
2015
Q4
$3.49M Buy
29,170
+346
+1% +$40K 2.05% 15
2015
Q3
$3.12M Sell
28,824
-324
-1% -$40.2K 1.91% 18
2015
Q2
$3.37M Sell
29,148
-4,374
-13% -$500K 1.87% 18
2015
Q1
$3.86M Sell
33,522
-16,213
-33% -$1.94M 1.89% 19
2014
Q4
$5.56M Sell
49,735
-21,240
-30% -$2.24M 2.16% 14
2014
Q3
$6.73M Sell
70,975
-19,435
-21% -$1.75M 1.95% 19
2014
Q2
$7.76M Sell
90,410
-1,416
-2% -$108K 1.82% 21
2014
Q1
$6.41M Sell
91,826
-38,252
-29% -$3.03M 1.51% 33
2013
Q4
$11M Sell
130,078
-48,208
-27% -$3.81M 2.49% 15
2013
Q3
$13.7M Sell
178,286
-11,738
-6% -$823K 2.48% 15
2013
Q2
$11.1M Buy
+190,024
New +$11.4M 2% 26

Other funds holding CELG

Garcia Hamilton & Associates's CELG Position: Q4 2017 in Review

Garcia Hamilton & Associates sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 3,974 shares — an estimated $579K sold.

Garcia Hamilton & Associates first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $13.7M in Q3 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Garcia Hamilton & Associates reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 3,974 Celgene Corp shares in Q4 2017, an estimated $579K.
  • Garcia Hamilton & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Garcia Hamilton & Associates's Celgene Corp position peaked at $13.7M in Q3 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.